Biomarker-Estimated Myocardial Injury Versus Imaging-Defined Infarct Size: Methodological Considerations Following the CELEBRATE Trial. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326003157?dgcid=rss_sd_all
Biomarker-Estimated Myocardial Injury Versus Imaging-Defined Infarct Size: Methodological Considerations Following the CELEBRATE Trial. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326003157?dgcid=rss_sd_all
“Biomarker-Estimated Myocardial Injury Versus Imaging-Defined Infarct Size: Methodological Considerations Following the CELEBRATE Trial.” American Journal of Kidney Diseases.
@article{article3299,
title = {Biomarker-Estimated Myocardial Injury Versus Imaging-Defined Infarct Size: Methodological Considerations Following the CELEBRATE Trial},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326003157?dgcid=rss_sd_all}
}